ФНФейгельман Софья Николаевна

Фейгельман Софья Николаевна

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Фейгельман Софья Николаевна has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Advanced diagnostic capabilities for cough assessment utilizing the neural network model «CoughScan»: findings from a prospective, comparative observational study

    by Andrey V. Budnevsky, Sergey N. Avdeev, Evgeniy S. Ovsyannikov, Vladimir N. Bondarev, Alexander V. Plastun, Sofia N. Feigelman, Valeria R. Drobysheva

    Background. Identifying the character, frequency, and intensity of cough is crucial in clinical practice, aiding in differential diagnosis, influencing treatment choices. «CoughScan» is a software with an embedded neural network model designed to assess cough frequency in real-time for diagnostic and monitoring purposes. Aim. To obtain additional data on the efficacy and safety of Rengalin® in the treatment of cough in adults with acute respiratory viral infections (ARVI) using both traditional and new intelligent technologies. Materials and methods. An observational study was conducted involving 60 patients with ARVI, receiving Rengalin® for cough management. Outpatient patients were divided into 2 groups: the main group (n=40) received Rengalin® for 7 days, while the control group (n=20) received no cough medication. The severity of symptoms of ARVI and cough was assessed with Cough severity scale (CSS), «CoughScan», Bronchitis Severity Scale (BSS). Results. The cough severity score on CSS decreased by 2.9 points in the Rengalin® group and by 1.5 points in the control group (p=0.0004). The average BSS score reduced by 1.3 units with Rengalin® and by 0.2 units in controls (p=0.0001). The mean duration of cough during treatment was 5.7±0.2 days versus 7.2±0.4 days without treatment (p=0.0178). Monitoring of daily cough intensity with «CoughScan» also showed a statistically significant advantage in the Rengalin® group (p0.0001). A non-inferiority test based on the area under the curve (AUC) over 7 days indicated comparable results between «CoughScan» and the CSS, with differences within 10%. Conclusion. «CoughScan» is a convenient and reliable tool for assessing cough dynamics in outpatient settings. Its data are comparable to the Cough severity scale regarding treatment efficacy, with antitussive activity of Rengalin® evident from the early days of therapy.

  • Open Access

    Acute myocardial injury in new coronavirus infection: contribution of mast cells

    by А. В. Будневский, S. N. Avdeev, E. S. Ovsyannikov, R. E. Tokmachev, С. Н. Фейгельман, V. V. Shishkina, I. M. Perveeva, T. A. Chernik, E. D. Arkhipova, S. A. Budnevskaya

    The new coronavirus infection, COVID-19, led to a global pandemic in 2019–2023. The infection affects not only the lung tissue, but also other organs and systems, including the heart. This causes the frequent development of myocarditis, arrhythmia, and acute coronary syndrome in these patients, as well as worsening of coronary heart disease and chronic heart failure. One of the important mechanisms of heart damage in COVID-19 is the excessive activation of mast cells, which produce cytokines and chemokines with pro-inflammatory activity, thus causing a so-called “cytokine storm” – a special severe form of systemic inflammatory reaction that can be fatal.The aim of the literature review was to analyze and summarize published data on cardiovascular complications in COVID-19, including the effect of mast cell proteases on myocardial damage.

  • Open Access

    Role of mast cell proteases in cardiac damage in new coronavirus infection

    by Andrey V. Budnevsky, Sergey N. Avdeev, Evgeny S. Ovsyannikov, Roman E. Tokmachev, Sofia N. Feygelman, Victoria V. Shishkina, Inna M. Perveeva, Tatyana A. Chernik, Ekaterina D. Arkhipova, Будневский Андрей Валериевич, et al.

    INTRODUCTION: Coronavirus Disease 2019 (COVID-19) is the cause of the global pandemic of 2019–2023. Despite the fact that COVID-19 primarily affects the lung tissue, cardiovascular complications are not uncommon both at the height of the disease, and in the post-COVID period. The presence of previous cardiovascular diseases and advanced age of the patient are proven risk factors of adverse outcomes in COVID-19. AIM: Based on the analysis of the current literature sources, to determine the role of mast cell proteases in the pathogenesis of cardiovascular complications of COVID-19. Excessive production of pro-inflammatory cytokines and chemokines by mast cells in the new coronavirus infection conditions the initiation of a severe systemic inflammatory response that affects not only the lung tissue, but also the myocardium. One most significant mechanism of the development of cardiovascular complications in patients with COVID-19 is endothelial dysfunction of the microcirculatory system with the formation of ischemic areas with subsequent local apoptosis of cardiac myocytes. CONCLUSION: Cardiovascular complications of COVID-19 develop primarily due to the damaging effect of proinflammatory cytokines, the production of which is stimulated by proteases of activated mast cells. Because of small amount of published data, additional investigation is required.

  • Open Access

    The Department of Medical Sciences of the RAS, Therapeutic Sciences Council meeting: Scientific projects marathon of Russian therapeutic departments "From innovative technologies and education to healthcare practice. Pulmonology: from real clinical practice to promising developments"

    by O. M. Drapkina, S. N. Avdeev, E. K. Beltyukov, V. V. Naumova, D. V. Kiseleva, А. В. Будневский, E. S. Ovsyannikov, С. Н. Фейгельман, R. E. Tokmachev, E. V. Garbuzova, et al.

    Заседание Совета по терапевтическим наукам Отделения медицинских наук РАН: Марафон научных проектов терапевтических кафедр России "От инновационных технологий и образования к практике здравоохранения. Пульмонология: от реалий клинической практики к перспективным разработкам"

  • Open Access

    Spectral tussophonobarography as a method for monitoring the effectiveness of cough treatment in patients with COVID-19

    by А. В. Будневский, S. N. Avdeev, E. S. Ovsyannikov, С. Н. Фейгельман

    Dry cough is one of the most common complaints of patients with COVID-19, so it must be treated with antitussives. The effectiveness of prescribed therapy can be controlled by using questionnaires and spectral analysis of cough sounds. The aim was to assess the use of spectral tussophonobarography for monitoring the effectiveness of cough treatment in patients with COVID-19. Methods. The main group consisted of 60 patients with COVID-19 (45% men, 55% women, average age 38.6 (30.1; 49.6) years) with mild or moderate severity and strong complaints of cough. The disease was treated in accordance with clinical recommendations, and antitussives were also used. Cough on the 1st and 8th days of therapy was studied using a visual analogue scale and spectral tussophonobarography, then compared with the induced cough of 30 healthy individuals making up the comparison group (43.3% men and 56.7% women; average age of 36.3 (28.4; 44.8) years). Cough recordings were subjected to a fast Fourier transform algorithm. The following cough characteristics were assessed: duration (ms), ratio of low and medium frequency energy (60 – 600 Hz) to high frequency energy (600 – 6000 Hz), and frequency of maximum sound energy (Hz). Not only of the coughing act as a whole was assessed, but also of each phase separately. Results. On the 8th day of treatment, significant changes in cough characteristics were seen compared to the 1st day, especially in the 2nd phase of the cough act. The duration of cough increased (T = 355.0 (276.0; 407.5) – on the 1st day; T(c) = 432.0 (386.0; 556.0) – on the 8th day; p = 0.0000), lower frequencies began to predominate (Q = 0.281 (0.2245; 0.408) – on the 1st day; Q(c) = 0.4535 (0.3725; 0.619) – on the 8th day; p = 0.0000), the frequency of maximum sound energy decreased (Fmax = 488.5 (282.0; 1220.5) – on the 1st day; Fmax = 347.0 (253.0; 488.0) – on the 8th day; p = 0.0064). No statistically significant differences were found in the studied parameters on the 8th day of treatment as compared with those in healthy individuals. Conclusion. Spectral tussophonobarography revealed that characteristics of cough sounds during treatment of COVID-19 were close to those of healthy individuals.


  • Open Access

    Diacylglycerides as nutrition components or precursors of carcinogens: a critical view on an ambular question

    by Andrey V. Budnevsky, Evgeniy S. Ovsyannikov, Valery I. Popov, Elena S. Drobysheva, Sofia N. Feigelman, Будневский Андрей Валериевич, Фейгельман Софья Николаевна

    Obesity is considered as a noninfectious epidemic worldwide. Metabolic disorders associated with the accumulation of adipose tissue lead to obesity-associated diabetes mellitus and cardiovascular diseases. Diet is a component of treatment of diseases associated with obesity. The most commonly used diets are caloric restriction by reducing fat in the diet. Over the years, there have been several attempts to use diacylglycerol (DAG) as components of dietary oils owing to its ability to suppress the accumulation of visceral fat and reduce postprandial levels of triacylglycerol and cholesterol and glucose in the blood serum. However, in 2009, it was found that when oil was processed at high temperatures during physical refining, DAG-enriched oil had the highest levels of potentially harmful glycidyl esters compared to conventional refined fats and oils. The study of the negative effects of glycidyl esters has prompted the food industry, which has traditionally used oil, to focus on strategies in preventing or mitigating these effects by changing the refining process or modifying deodorization equipment to reduce or eliminate process contaminants.

  • Open Access

    Effectiveness of Peripheral Antitussives in Patients with Dry Postinfectious Cough

    by Andrey V. Budnevsky, Evgeniy S. Ovsyannikov, Sofia N. Feigelman, Avag G. Kitoyan, Sofia A. Budnevskaya

    Background: Postinfectious dry cough can significantly worsen the quality of life of patients, which forces them to seek medical help. To relieve this symptom, peripheral antitussive agents are most often used, since they have a high profile of effectiveness and safety. Subjects and Methods: The study used levodropropizine, which was prescribed to a study group consisting of 100 patients with dry postinfectious cough, at a dosage of 10 ml (60 mg) 3 times a day for 7 days. The comparison group consisted of 34 patients with dry postinfectious cough who refused to take levodropropizine or had contraindications to taking it. On the 1st, 4th, and 8th days of the study, complaints were collected, an objective examination, and an assessment of cough intensity using 6-point scales for evaluating day and night cough, as well as a Visual Analog Scale were conducted. In addition, undesirable side effects were assessed at each visit. Results: It was found that during 7 days of treatment with levodropropizine, the intensity of cough on the above-mentioned scales significantly decreased, and no side effects were observed in any patient. Conclusions: The resolution of the cough syndrome occurred faster when taking a peripheral antitussive drug (levodropropizine). Moreover, no side effects were reported in any of the subjects. Therefore, peripheral antitussives have a high efficacy and safety profile against dry postinfectious cough.


  • Open Access

    Involvement of Mast Cells in the Pathology of COVID-19: Clinical and Laboratory Parallels

    by Andrey V. Budnevsky, Sergey N. Avdeev, Djuro Kosanovic, Evgeniy S. Ovsyannikov, Inessa A. Savushkina, Nadezhda G. Alekseeva, Sofia N. Feigelman, Viktoria V. Shishkina, Andrey A. Filin, Dmitry I. Esaulenko, et al.

    Recent studies suggested the potential role of mast cells (MCs) in the pathology of coronavirus disease 2019 (COVID-19). However, the precise description of the MCs’ activation and the engagement of their proteases is still missing. The objective of this study was to further reveal the importance of MCs and their proteases (chymase, tryptase, and carboxypeptidase A3 (CPA3)) in the development of lung damage in patients with COVID-19. This study included 55 patients who died from COVID-19 and 30 controls who died from external causes. A histological analysis of the lung parenchyma was carried out to assess the protease profiles and degranulation activity of MCs. In addition, we have analyzed the general blood test, coagulogram, and C-reactive protein. The content of tryptase-positive MCs (Try-MCs) in the lungs of patients with COVID-19 was higher than in controls, but their degranulation activity was lower. The indicators of chymase-positive MCs (Chy-MCs) were significantly lower than in the controls, while the content of CPA3-positive MCs (CPA3-MCs) and their degranulation activity were higher in patients with COVID-19. In addition, we have demonstrated the existence of correlations (positive/negative) between the content of Try-MCs, Chy-MCs, and CPA3-MCs at different states of their degranulation and presence (co-adjacent/single) and the levels of various immune cells (neutrophils, eosinophils, basophils, and monocytes) and other important markers (blood hemoglobin, activated partial thromboplastin time (aPTT), international normalized ratio (INR), and fibrinogen). Thus, the identified patterns suggest the numerous and diverse mechanisms of the participation of MCs and their proteases in the pathogenesis of COVID-19, and their impact on the inflammatory process and coagulation status. At the same time, the issue requires further study in larger cohorts of patients, which will open up the possibility of using drugs acting on this link of pathogenesis to treat lung damage in patients with COVID-19.


  • Open Access

    Spectral analysis of cough sounds of patients with COVID-19

    by А. В. Будневский, S. N. Avdeev, E. S. Ovsyannikov, С. Н. Фейгельман, O. N. Choporov, A. V. Maximov, A. V. Pertsev

    Cough is a frequent manifestation of COVID-19 (COronaVIrus Disease 2019), therefore, it has an important diagnostic value. There is little information about the characteristics of cough of COVID-19 patients in the literature. To perform a spectral analysis of cough sounds in COVID-19 patients in comparison with induced cough of healthy individuals. Methods. The main group consisted of 218 COVID-19 patients (48.56% – men, 51.44% – women, average age 40.2 (32.4; 50.1) years). The comparison group consisted of 60 healthy individuals (50.0% men, 50.0% women, average age 41.7 (31.2; 53.0) years) who were induced to cough. Each subject had a cough sound recorded, followed by digital processing using a fast Fourier transform algorithm. The temporal-frequency parameters of cough sounds were evaluated: duration (ms), the ratio of the energy of low and medium frequencies (60 – 600 Hz) to the energy of high frequencies (600 – 6 000 Hz), the frequency of the maximum sound energy (Hz). These parameters were determined in relation to both the entire cough and individual phases of the cough sound. Results. Significant differences were found between some cough parameters in the main group and in the comparison group. The total duration of the coughing act was significantly shorter in patients with COVID-19, in contrast to the induced cough of healthy individuals (T = 342.5 (277.0; 394.0) – in the main group; T (c) = 400.5 (359.0; 457.0) – in the comparison group; p = 0.0000). In addition, it was found that the cough sounds of COVID-19 patients are dominated by the energy of higher frequencies as compared to the healthy controls (Q = 0.3095 (0.223; 0.454) – in the main group; Q (c) = 0.4535 (0.3725; 0.619) – in the comparison group; p = 0.0000). The maximum frequency of cough sound energy in the main group was significantly higher than in the comparison group (Fmax = 463.0 (274.0; 761.0) – in the main group; Fmax = 347 (253.0; 488.0) – in the comparison group; p = 0.0013). At the same time, there were no differences between the frequencies of the maximum energy of cough sound of the individual phases of cough act and the duration of the first phase. Conclusion. The cough of patients with COVID-19 is characterized by a shorter duration and a predominance of high-frequency energy compared to the induced cough of healthy individuals.